Ashley Sant is a pharmacist who is specialized in Oncology in Johnson City, Tennessee. Patients can reach her at 1 Professional Park Dr Ste 21, Johnson City or contact her on 423-232-6983. Active license number of Ashley Sant is 34204 for Oncology in Tennessee. Ashley Sant is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Ashley Sant speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ashley Sant
Specialization:
Oncology
Credentials:
PHARMD, BCPS, BCOP
Gender:
Female
Location:
1 Professional Park Dr Ste 21, Johnson City, Tennessee, 37604-6909
Phone:
423-232-6983
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ashley Sant are as mentioned below.
NPI Number:
1295306058
NPI Enumeration Date:
02 Jul, 2021
NPI Last Update On:
02 Jul, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ashley Sant are as mentioned below.
Specialization
License Number
State
Status
Oncology
34204
Tennessee
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
313 New Bethel Rd, Piney Flats, Tennessee
Zip:
37686-4030
Phone Number:
276-791-1699
Fax Number:
--
Patients can reach Ashley Sant at 1 Professional Park Dr Ste 21, Johnson City, Tennessee or can call on phone at 423-232-6983.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.